Ropes & Gray LLP has an experienced and established team, which has a strong record across both issuer and underwriter representation. In a slow market, the firm has continued to demonstrate its excellence in IPOs, follow-on offerings, SPAC IPOs and de-SPAC transactions, and at-the-market offerings. It stands out for its expertise in representing private equity firms and their portfolio companies, along with biotech and pharmaceutical companies. New York partners Rachel Phillips, Faiza Rahman, Christopher Capuzzi and Paul Tropp are key names, along with Craig Marcus in Boston.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Hayward Holdings
- The Hillman Group
- Ecovyst Catalyst Technologies
- Ginkgo Bioworks
- ImmunoGen
- Lilium NV
- LSB Industries
- Rallybio Corporation
- Sarepta Therapeutics
- TransMedics
Highlight-Mandate
- Represented Hayward Holdings and CCMP Capital Advisors, a selling stockholder, in two secondary offerings of shares of Hayward’s common stock.
- Represented TransMedics Group in its follow-on underwritten public offering of 3.25m shares of common stock.
- Represented Ecovyst and its selling stockholder, CCMP Capital Advisors, in several equity transactions worth an aggregate of $579m.
Anwält*innen
Praxisleitung
Craig Marcus; Paul Tropp
Weitere Kernanwält*innen
Rachel Phillips, Faiza Rahman, Christopher Capuzzi